EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CCL5 hi Macrophages Interact with CD8 + T Cells and Potentiate Responsiveness to PD‐1 Blockade Plus Chemotherapy in Esophageal Squamous Cell Carcinoma

Yuanzhen Ma, Xiaodong Su, Tingting Zeng, Chunlian Zhou, Guozhen Yang, Zengfei Xia, Chufeng Zeng, Jiarong Zhan, Xin-Yuan Guan, Xu Zhang, Yan Li iD

Advanced Science · 2025

DOI: 10.1002/advs.202409187 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Yuanzhen Ma und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guan…. Hauptthemen laut MEDLINE: Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, CD8-Positive T-Lymphocytes, Chemokine CCL5. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guangdong Esophageal Cancer Institute Project, Guangdong Basic & Applied Basic Research-Hybribio Joint Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunotherapy has significantly transformed cancer therapy and reinvigorated research in cancer immunology. Several clinical trials have employed neoadjuvant immunochemotherapy (NIC) for advanced esophageal squamous cell carcinoma (ESCC), resulting in significant benefits for many patients. However, response rates remain limited, underscoring the need for more effective screening methods and novel therapeutic strategies. Tumor‐associated macrophages (TAMs) have been shown to play a crucial role in tumor progression and impact the clinical outcomes of cancer patients. Nonetheless, it is worth noting that TAMs exhibit phenotypic and functional heterogeneity. In this study, a distinct population of CCL5 hi macrophages is identified that plays a critical role in ESCC when treated with immunochemotherapy. Furthermore, insights are gained into the underlying mechanisms, revealing the existence of a feedback loop involving IFN‐γ, CCL5 hi macrophages, and CD8 + T cells within the tumor microenvironment of ESCC undergoing immunochemotherapy. Specific signatures associated with CCL5 hi macrophages are correlated with a better response to immunochemotherapy in patients with ESCC. Moreover, the in vivo experiments demonstrate that CCL5 supplementation enhances the effectiveness of immunochemotherapy. This research contributes to the optimization of patient stratification and provides a rationale for novel combinatorial approaches involving immunotherapy in the treatment of ESCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal Squamous Cell CarcinomaEsophageal NeoplasmsCD8-Positive T-LymphocytesChemokine CCL5MacrophagesTumor-Associated MacrophagesProgrammed Cell Death 1 ReceptorAnimalsMiceHumansTumor MicroenvironmentImmunotherapyFemaleImmune Checkpoint InhibitorsMaleCell Line, Tumor

Stichwörter der Autor:innen

CCL5CD8+ T cellsPD‐1esophageal squamous cell carcinomaimmunochemotherapymacrophages

Substanzen

Chemokine CCL5Programmed Cell Death 1 ReceptorCCL5 protein, humanImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.
  • Guangdong Esophageal Cancer Institute, Department of Thoracic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
  • Department of Clinical Oncology, The University of Hong kong, Hong Kong, China.

ORCID-Profile: Yan Li

Förderung

  • National Natural Science Foundation of China
  • Guangdong Esophageal Cancer Institute Project
  • Guangdong Basic & Applied Basic Research-Hybribio Joint Fund

Zitieren

APA

Ma, Y., Su, X., Zeng, T., Zhou, C., Yang, G., Xia, Z., Zeng, C., Zhan, J., Guan, X. Y., Zhang, X., & Li, Y. (2025). CCL5 hi Macrophages Interact with CD8 + T Cells and Potentiate Responsiveness to PD‐1 Blockade Plus Chemotherapy in Esophageal Squamous Cell Carcinoma. Advanced Science. https://doi.org/10.1002/advs.202409187

Vancouver

Ma Y, Su X, Zeng T, Zhou C, Yang G, Xia Z, et al. CCL5 hi Macrophages Interact with CD8 + T Cells and Potentiate Responsiveness to PD‐1 Blockade Plus Chemotherapy in Esophageal Squamous Cell Carcinoma. Advanced Science. 2025. doi:10.1002/advs.202409187

BibTeX
@article{Ma2025,
  author = {Ma, Yuanzhen and Su, Xiaodong and Zeng, Tingting and Zhou, Chunlian and Yang, Guozhen and Xia, Zengfei and Zeng, Chufeng and Zhan, Jiarong and Guan, Xin-Yuan and Zhang, Xu and Li, Yan},
  title = {CCL5 hi Macrophages Interact with CD8 + T Cells and Potentiate Responsiveness to PD‐1 Blockade Plus Chemotherapy in Esophageal Squamous Cell Carcinoma},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202409187}
}
Kostenlos starten →